NCT07090928View on ClinicalTrials.gov

Effectiveness of Per-Operative Bupivicaine in Reducing Postoperative Pain at Port Site and Improving Mobility in Knee Arthoscopic Procedures

PHASE4Not yet recruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

August 1, 2025

Primary Completion Date

January 31, 2026

Study Completion Date

March 31, 2026

Conditions
Arthroscopic Surgery
Interventions
DRUG

5 ml of 0.5% bupivacaine infiltrated at each port site

5 ml of 0.5% bupivacaine infiltrated at each port site after the arthroscopic procedures

DRUG

Placebo

5ml 0.9%normal saline infiltrated at port site

All Listed Sponsors
lead

Khyber Teaching Hospital

OTHER